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In 2015, over 9.5% of Americans have diabetes and 95% of them are diagnosed with type 2 
diabetes (T2D). [1] While existing treatments are not effective enough, more efficient treatment 
is needed. Macrophage is a type of white blood cell that plays a crucial role in the immune 
system by digesting foreign substances. It can differentiate into two phenotype macrophages: M1 
“killing” phenotype that can exacerbate T2D condition and M2 “healing” phenotype that can 
ease T2D symptoms.[4] Researchers have found out that under T2D condition, the number of 
M1 phenotype macrophages dominates over that of M2 phenotype. Thus, a possible treatment 
for T2D is to find ways to shift M1phenotype to M2 phenotype. While the macrophage can 
polarize and repolarize to different phenotypes depending on different stimulations, we found 
that M1 macrophage can polarize to M2 phenotype on the microtextured culture. [4] Thus, the 
objectives of this project are to test the efficacy of M2 polarization with microtextured culture. 
This project will utilize micro-patterned topography to reprogram macrophages from diabetic 
mice in vitro and probe the mechanism of the shift. Then we will evaluate the potency of such 
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Chapter 1. Introduction 
 
Type 2 Diabetes is a common chronic disease associated with insulin resistance of cells 
in the body. When the digestive tract absorbs glucose in food, the glucose enters the blood 
vessels and thus increases the blood sugar level. The rise of glucose concentration in blood is 
then sensed by beta cells located in the pancreas. In order to maintain the homeostasis, those beta 
cells secrete insulin, which can be received by insulin receptors on the surface of cells in the 
body. The activation of insulin receptors enables cells to absorb the glucose from the blood for 
activities and thus decreases the blood sugar level. In the case of T2D, the receptors on other 
cells of the body are malfunctioning, and therefore the glucose level in blood cannot be 
regulated, leading to hyperglycemia. Long term of hyperosmolar hyperglycemic state might 
cause obesity, cardiovascular diseases and kidney failures, which makes it the 7th leading cause 
of death in the U.S [1].  
Over the past several decades, treatments have been invented for T2D. Some focus on 
behavioral treatment such as exercise and diet, others require oral or injectable medications. 
While a change of lifestyle is a long and complicated progress, medicine especially metformin 
can increase insulin sensitivity of cells, slow down the absorption of glucose from food and slow 
down the release of glucose in the liver [2]. However, those treatments can be either time-
consuming or palliative [3]. Since there is still a huge number of T2D patients, there is an urgent 
need to discover new effective treatments.  
Macrophages are important cells of the immune system. Associated with obesity, they 
can be found accumulated in adipose tissue (visceral fat) and bone marrow [11]. A research 
shows that macrophages can acquire different phenotypes such as M1 and M2 depending on the 
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microenvironment [4]. M1 (pro-inflammatory) can trigger Th1 immune response and kill 
microorganisms if exposed to specific signals, but it also increases insulin resistance. M2 (anti-
inflammatory), on the other hand, helps tissue and vascular to repair by triggering Th2 immune 
response and decreases insulin resistance [4]. Interestingly, M1 and M2 phenotypes have been 
found closely related to T2D: M1 numbers and M1/M2 ratio are associated with insulin 
resistance [5]. And since insulin resistance is one of the most important factors correlated to 
T2D, it is possible to find a way to cure T2D by manipulating the ratio of M1/M2.  
Microscale topography, a technology that modifies surfaces with microscale texture, has 
been used frequently in various fields of science. Contact guidance is the phenomenon where 
cells contact with their microenvironments and thus adjust the cytoskeleton, which changes the 
behavior, morphology, or even phenotype depending on the texture or structure of the 
microenvironment they make contact with. Besides soluble factors presented in the 
microenvironment, research also finds that the surface texture where macrophages attached to is 
also important for the polarization of macrophages [6]. More specifically, elongated shape and 
groove with a particular width can trigger contact guidance phenomenon that leads to the 
expression of M2 phenotype in healthy macrophage [6,7]. However, currently there is no 
research associating macrophage polarization with T2D treatment. Hence, using topography to 
control the M1/M2 ratio of T2D macrophage could be a potential solution to treat T2D. 
ROCK-1/2 are proteins found to play roles in macrophage polarization by regulating the 
cell skeleton, glucose and fatty acid transport, and NF phosphorylation [8,9,10]. Before 
jumping into in vivo study of how the reprogrammed macrophages could affect the T2D, we 
decided to investigate the underlining mechanism of how ROCK-1/2 stimulated by topography 
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could impact the glucose and fatty acid transporters by inhibiting the ROCK-1/2 proteins in 
macrophages and evaluating the M1/M2 markers after treatments [12]. 
Micro-topography is relatively new microtechnology using neither biological nor 
chemical approaches to treat diseases. Compared to medical treatment for T2D, micro-
topography might have less to no side effects on the body, and it might be able to treat T2D once 
and for all. It is also a more practicable method compared to changing of lifestyles. The ability to 
manipulate the M1/M2 ratio could be utilized to treat other immune system problems as well 
since M1 and M2 macrophages have lots of other functions too. Since this therapy will use 
PBMCs from the patient for M2 polarization, there will be no immune rejection after injecting 
M2 cells back to the patient. The therapy could also be designed for different patients under 
different conditions for different outcomes too. We hypothesize that the micro-patterned 










Chapter 2. Materials and Methods 
 
2.1 Patterned PDMS preparation 
 Silicon wafers with micro-patterned (2m wide, 1.5m tall, spaced by 2m) were made 
according to standard photolithography technique using S1813 photoresist. Curing base and 
curing agent (Sylgard 184) were mixed with a ratio of 10:1 with a total mass of 16g per 
Polydimethylsiloxane (PDMS) plate to be made. The mixture was put into a vacuum for 10 
minutes to remove the air bubbles appeared during mixing. Silicon wafer with micro-pattern was 
placed in the center of a spinner and fixed by vacuum. 6mL of curing mixture were added on the 
surface of the wafer. The wafer was spun at 300 RPM for 1 minute. The wafer with PDMS was 
then placed in a 15mL petri dish. The dish was then sent to incubate at 65°C for 2 hours or 
incubate at room temperature for 48 hours. The solidified PDMS plate was then carefully 
removed from the silicon wafer. This process is shown in Figure 1. 
 
Figure 1: Soft lithography of PDMS [13] 
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Six circles with the size smaller than a well in 6-wells plate were cut and placed into 6-
wells plate with the textured side facing up. The wells were washed with 2mL of phosphate-
buffered saline (PBS), 2mL of 70% Ethanol, 2mL of PBS again. The liquids were aspirated. The 
6-wells plate was sterilized under UV light for 2 minutes. 
2.2 Animal use 
The care and use of animals observed NIH guidelines and were approved by the Ohio 
State University Institutional Animal Care and Use Committee. Obese male mice with db/db 
mutation that induces type 2 diabetes via hyperphagia were used as treatment groups for this 
study. 
2.3 Bone marrow isolation & cell culture 
Mice were sacrificed with Carbon dioxide. Femurs and tibias were isolated from both 
hind limbs washed with PBS and placed into plain Dulbecco's Modified Eagle Medium (DMEM) 
on ice. Femurs and tibias were washed by PBS, 75% Ethanol and PBS. Both ends of the femurs 
and tibias were cut. A syringe was filled with plain DMEM. The bone marrow was removed by 
pressing the plain DMEM through the femurs and tibias with the syringe. The mixture of DMEM 
and bone marrow was resuspended until no clots were visible, centrifuged at 4°C with 1000 
RPM for 10 minutes, and aspirated. 10mL of red blood cell lysis (distilled & deionized water to 
RBC lysis solution name ratio: 10:1) was added and incubated for 10 minutes to break the red 
blood cells. The solution was then centrifuged and aspirated. BSA and CD11b Microbeads were 
added at a ratio of 9:1 to label the targeting monocytes, the progenitor of bone marrow-derived 
macrophages (BMDMs) with magnetic antibodies. The solution was passed through a MS 
column in QuadriMACSTM separator to filter out unwanted cells. The column was then removed 
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from the magnetic field and 9mL of BSA was used to wash the monocytes off the column. 
Monocytes labeled with antibodies were collected in a separate Eppendorf tube, counted, 
centrifuged and aspirated. 2 million of cells were cultured with mix macrophage media 
(IMDM+Gluta-max, 10% inactivated FBS, 1% ANTI/ANTI, 0.1% Granulocyte-macrophage 
colony-stimulating factor (GM-CSF), which stimulates stem cells to produce monocytes) in each 
well of the 6-wells plate (with micro-patterned PMDS). Plain-patterned PDMS served as another 
control in comparison to micro-patterned PDMS to demonstrate the effects that micro patterns 
have on cells. Plate was incubated in incubator at 37 °C. 
At day 3 of incubation, the old media was aspirated and fresh media was added. Cells 
were treated with either ROCK1 (Y-27632) at concentrations of 0M, 50M and 100M or 
ROCK2 (KD025) at concentrations of 0M and 25M. Non-treated cells cultured in micro-
patterned PDMS served as positive controls while cells cultured in plain PDMS served as 
negative controls. 
2.4 Cell collection 
Cells were collected at day 7 for qRT PCR, western blot. For PCR, wells were aspirated 
and washed with 1mL PBS. After incubation at room temperature for 5 minutes, PBS was 
removed and 1mL of TRizol reagent (ThermoFisher) was added. Following another 5 minutes of 
incubation, cells were scratched, collected in 2mL Eppendorf tube and stored at -80°C. For 
western blot, wells were washed with PBS, aspirated and added with 1mL of cold PBS with 
ethylenediaminetetraacetic acid (EDTA) After incubation at 37°C for 10 minutes, the PBS was 
aspirated. The cells were collected after centrifuge and aspiration. 
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2.5 Quantitative gene expression analysis 
Total RNA was extracted from cells collected at day 7 using TRizol reagent according to 
manufacturer’s instructions. RNA samples were used for the synthesis of cDNA using the 
SuperScript® VILO cDNA Synthesis Kit (ThermoFisher). Quantitative real-time PCR was 
performed by the QuantStudio 3 Real-Time PCR System with TaqMan fast advance chemistry 
(Thermo Scientific) using mouse gene-specific primers for M1and M2 macrophage markers to 
determine mRNA levels per cell. Primer names shown below in Table 1. 
M1 markers TNF IL6 CCR2 NOS2 IL1b 
M2 markers IL10 ARG1 VEGFA   
Internal 
controls 
18S GAPDH    
 
Table 1:  Mouse gene-specific primers used in this study. 
Tumor necrosis factor alpha (TNF) is a cytokine mainly produced by macrophages in 
respond of systemic inflammation [14]. Interleukin 6 (IL6) can be found both being pro-
inflammation cytokines and anti-inflammation cytokines. When IL6 is signaling in macrophage, 
it creates pro-inflammatory response [15]. Chemokine receptor type 2 (CCR2) encodes a 
receptor that involves in monocyte infiltration and inflammatory response [16]. Nitric oxide 
synthase (NOS2 or iNOS) can be found in monocytes or macrophages from patients with 
inflammatory diseases [17]. Interleukin 1 beta (IL1b) functions as a mediator of inflammatory 
response 
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For M2 markers, those markers can be found in anti-inflammatory macrophages. 
Interleukin 10 (IL10) is capable of inhibiting the synthesis of pro-inflammatory cytokines such 
as TNF. Arginase 1 (ARG1) encodes the arginine production, which relates to the production 
of polyamines and collagen and favors tissue remodeling and wound healing [18]. And finally, 
vascular endothelial growth factor A (VEGFA) is responsible for vascularization of endothelial 
cells and macrophage migration. 
18S is important for ribosomal function and thus frequently used for PCR. 
Glyceraldehyde 3-phospate dehydrogenase (GAPDH) plays a crucial role in glycolysis, and thus 
is considered as a housekeeping gene. Both 18S and GAPDH will serve as internal control in this 
study. 
2.6 Statistical analysis 
Data were analyzed using Excel and SPSS. We used n = 3–5 replicates per experiment. 
Specific information on the number replicates, and statistical tests can be found in the figure 
legends. The difference of cytokine expression between treatment group and control group will 









Chapter 3. Results and Discussion 
Before the concentrations of ROCK1/2 inhibitors were determined, the original 
concentrations were set as 20M for ROCK1 and 20M for ROCK2. However, those 
concentrations seemed not to have significant impacts on the fold changes and expression levels 
of M1 and M2 markers. Thus, instead of moving to mice injection of reprogrammed 
macrophages, we decided to find the most suitable concentrations for ROCK1/2 inhibitor to 
probe the role of ROCK1/2 in topographical reprogramming. 
At day 1, the bone marrow was collected from mice femurs and tibias. By treating the 
bone marrow with red blood cell lysis and magnetic separator, most of the red blood cells and 
platelets were filtered, leaving only white blood cells. The white blood cells were stimulated by 
GM-CSF in media and differentiated into monocytes, which then differentiated into 
macrophages. 
At day 3 before treatment, macrophages were found attaching to the micro-patterned 
surface of PDMS. Most of the cells changed from round shapes into linear shapes aligning with 
the micro-patterned on the surface. We could safely conclude that linear-shaped cells 
successfully attach to pattern whilst those float round-shaped cells are dead.  
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Figure 2: Image of macrophages attaching to the micro patterns. 
To illustrate the fact that micro-patterned topography has changed the cell morphology, 
we cultured monocytes on plain-patterned PDMS as well. Macrophages grown on plain patterns 
had more random shapes with multiple “synapsis-liked” features while those cultured on micro-
patterned topography aligned with the patterns in linear shapes via contact guidance. 
 By treating macrophages with ROCK-1/2 inhibitors, ROCK-1/2 proteins will be 
inhibited due to the inhibitors competing with ATP for binding to the catalytic sites, while the 
uninhibited ROCK protein will be stimulated preferentially. 
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Figure 3: Quantitative PCR results in comparison to GAPDH of db/db mice macrophages treated with ROCK-1 inhibitor with a concentration of 
50uM. The top four genes represented M1 markers while the lower three genes represented M2 markers. (One-tailed test, n=3 per treatment). 
 
Figure 4: Quantitative PCR results in comparison to 18S of db/db mice macrophages treated with ROCK-1 inhibitor with a concentration of 
50uM. The top four genes represented M1 markers while the lower three genes represented M2 markers. (One-tailed test, n=3 per treatment). 
From figure 3&4, we can see an approximate trend where M2 markers expressed more in 
treatment groups while M1 markers expressed more in control groups. This makes sense because 
those macrophages were inhibited with 50uM of ROCK-1 inhibitor, which lead to ROCK-2 
stimulation by the micro-topography. However, not all of the genes responded in the same 
manner. CCR2 and NOS2 cytokines gene expressions in macrophages treated with ROCK-1 
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inhibitor were higher than those in untreated control groups. The statistical analysis also revealed 
insignificance. One possible reason could be due to the fact that the sample size is limited at 3, 
which could be improved by adding more replicates. It could also because that the concentration 
of the ROCK-1 inhibitor was not high enough such that the differences between inhibited and 
uninhibited macrophage gene expressions were not significant. Thus, we decided to increase the 
concentration of ROCK-1 inhibitor to 100uM. 
 
Figure 5: Quantitative PCR results in comparison to GAPDH of db/db mice macrophages treated with ROCK-1 inhibitor with a concentration of 
100uM. The top four genes represented M1 markers while the lower three genes represented M2 markers. (One-tailed test, n=4 per treatment). 
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Figure 6: Quantitative PCR results in comparison to 18S of db/db mice macrophages treated with ROCK-1 inhibitor with a concentration of 
100uM. The top four genes represented M1 markers while the lower three genes represented M2 markers. (One-tailed test, n=4 per treatment). 
At a concentration of 100uM, the impacts that ROCK-1 inhibitor has on db/db mice 
macrophages became more obvious. The M1 markers expression in control group were 
consistently higher than those in treatment group judging from the mean gene expression levels. 
M2 markers also followed the same trend as we saw in 50uM ROCK-1 inhibitor treatment. As a 
result, 100uM of ROCK-1 inhibitor seemed to work better at investigating the role of ROCK-1/2 
in topography reprogramming since all M1 markers showed similar responses that would be 
easier to identify when probing the role of ROCK-1/2. Combined the ROCK-1 inhibitor results, 
we can see that there might be correlations between the ROCK-1 inhibitor and M1 marker 
expressions, and between the ROCK-1 inhibitor and M2 marker expressions. 
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Figure 7: Quantitative PCR results in comparison to GAPDH of db/db mice macrophages treated with ROCK-2 inhibitor with a concentration of 
25uM. The top four genes represented M1 markers while the lower three genes represented M2 markers. (One-tailed test, n=5 per treatment). 
 
Figure 8: Quantitative PCR results in comparison to 18S of db/db mice macrophages treated with ROCK-2 inhibitor with a concentration of 
25uM. The top four genes represented M1 markers while the lower three genes represented M2 markers. (One-tailed test, n=5 per treatment). 
After treated with 25uM of ROCK-2 inhibitor, db/db mice macrophages showed 
generally higher expressions of M1 markers and lower expressions of M2 markers compared to 
untreated control groups with the exceptions of TNFa, and VEGFA expressions. This result 
demonstrated that the inhibition of ROCK-2 proteins in diabetic mice macrophages may lead to 
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ROCK-1 stimulation that favors glucose uptake/metabolism (M1 phenotype). However, the 
existence of outliers such as TNFa, and VEGFA should not be neglected. Future work should be 
set to investigate the relationships between those cytokines and diabetic mice macrophage 
phenotype. 
Another thing to notice about the ROCK-2 inhibitor treatment is that the 25uM 
concentration seemed to be harmful for the macrophages. In figure 9, the groups treated with 
25uM of ROCK-2 inhibitor had much more floating dead cells compared to the untreated control 
groups, which indicated that such concentration might kill macrophages. Study has found that 
ROCK-1 is involved in destabilizing actin cytoskeleton while ROCK-2 is required for stabilizing 
actin cytoskeleton, which further explains the reason why ROCK-2 inhibitor at much lower 
concentration could kill cells: the inhibition of ROCK-2 will destabilize actin cytoskeleton, 
which is crucial for macrophages to attach to the micro-patterned PDMS [19]. Thus, it’s 
necessary to decrease the concentration of ROCK-2 inhibitor in the future study.  
 
Figure 9: Microscopic images of diabetic mice macrophages treated with ROCK-2 25uM inhibitor (left) and control group (right).  
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The image on the left has more round cells. 
As the statistics indicated for each cytokine expression level, most of the p values are not 
significant. The major reason I could think of is the fact that the sample size is really small, with 
macrophages collected from 1 to 2 mice per treatment. Thus, the results might remain 



















Chapter 4. Conclusion 
 
4.1 Summary 
The purpose of this study is to probe the role of ROCK-1/2 in diabetic mice macrophages 
reprogrammed by micro-patterned topography. Our hypothesis is that at low level of ROCK-1 
proteins, the micro-patterned topography could stimulate the ROCK-2 proteins and thus leading 
to a M2 phenotype. To investigate the role, we treated the macrophages with ROCK-1/2 inhibitor 
at different concentration separately to see how the micro-patterned topography could help 
stimulate the uninhibited ROCK protein and evaluated the M1 & M2 markers expressions of the 
cells to speculate the outcomes.  
As a result, while ROCK-1 50uM inhibitor might not generate a good outcome for the 
investigation of the role of ROCK-1/2, ROCK-1 100uM inhibitor and ROCK-2 25uM inhibitor 
appeared to be effective for us to probe the role of ROCK-1/2 in topographically stimulated 
macrophages as the M1 and M2 markers tent to have more consistent results. We could see that 
compared to the untreated control group, the macrophages treated with ROCK-1 100uM 
inhibitor had higher expression of M2 markers. This may demonstrate the fact that at low 
ROCK-1 levels, micro-patterned topography could stimulate ROCK-2 production, leading to a 
M2 phenotype. However, we still need to test the levels of ROCK-1/2, GLUT-1 and CD36 to 
make a conclusion. 
Diabetic mice macrophages treated with ROCK-2 25uM inhibitor yielded the opposite 
outcome, where treatment group had higher M1 markers expressions than control group. This 
might illustrate that the inhibition of ROCK-2 proteins in diabetic mice macrophages may lead to 
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ROCK-1 stimulation. However, we can’t make any conclusions about the ROCK-2 stimulation 
by micro-patterned topography in this case. The concentration of ROCK-2 inhibitor was so high 
that it may have damaged the actin cytoskeleton and thus killed the macrophages according to 
the result.  
In conclusion, ROCK-1 inhibitor at a concentration of 100uM could be useful for the 
stimulation ROCK-2 production via micro-patterned topography. This may indicate that ROCK-
1 proteins at lower concentration could help to increase the stimulation of ROCK-2 by micro-
patterned topography, and thus leading to a M2 macrophage phenotype. 
4.2 Limitations 
Due to time limitation, this study has only finished part of the original experiment. 
Sample size, for example, was three to five, which is considered small to generate statistically 
significant results. We will need to run western blot to detect the protein levels of ROCK-1/2, 
GLUT-1 and CD36 and flow cytometry to evaluate the phenotype of macrophages after 
inhibition. Another limitation is the lack of samples cultured on plain patterns, which could be 
used to probe the effects inhibitors have on cells. In other words, we need to demonstrate that it 
was the micro-patterned topography that stimulated the ROCK-2 proteins when macrophages 
were treated with inhibitors. In addition, the throughput of the bone marrow isolation process is 
low. Each mouse could only provide 4 to 6 wells with each well having around 2 million cells, 
which is required for macrophages to grow since they live in high confluency environment 
naturally. 
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4.3 Future work 
To better test the hypothesis that the micro-patterned topography could stimulate the 
ROCK-2 proteins and thus leading to a M2 phenotype, further tests to identify the protein levels 
as well as macrophage phenotype are needed. In addition, it’s important to include another 
control group where having plain-patterned PDMS will serve as the negative control, while 
having inhibitors as positive control to ensure that it is the micro-patterned topography that is 
stimulating the macrophages to express more ROCK-2 genes. Future work is also needed to 
improve the protocol of bone marrow isolation so that the throughput would be higher. 
As the hypothesis of this study is tested, our next step would be to test the M2 
macrophages reprogrammed by micro-patterned topography based on the findings of this study 
by injecting those cells back to the visceral fat compartment of db/db mice to evaluate how 
reprogrammed cells will shift the M1/M2 ratio in vivo and thus affect the outcome. 
 
4.4 Contribution 
The silicon wafer with micro-patterned topography was manufactured by NanoTech 
West. The bone marrow isolation and cell culture protocols were developed by Silvia Duarte-
Sanmiguel and Daniel Gallego-Perez, PhD. I designed the experiment, made the PDMS, isolated 
the bone marrow, collected the cells, ran the qPCR and analyzed the data. Guidance for this 
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